Search - tctmd.com

Displaying 141 - 160 of 319

Sort: Relevancy | Date

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

Presentation TCT 2013

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Presenter: Peter Smits

October 29, 2013

Presentation TCT 2013

Everolimus-eluting Stents in Left Main Disease: The ULMD Florence PCI Registry (with Angiographic Follow-up)

Presenter: David Antoniucci

October 28, 2013

Presentation TCT 2013

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

Presenter: Young-Hak Kim

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

Prior Cancer Diagnosis Increases Mortality Risk After Primary PCI for STEMI

L.A. McKeown

September 27, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

News Daily News

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Yael L. Maxwell

September 13, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Industry News

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

July 10, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Plavix and PPI

June 28, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

L.A. McKeown

June 07, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

Advertisement

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Everolimus-eluting Stents in Left Main Disease: The ULMD Florence PCI Registry (with Angiographic Follow-up)

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Prior Cancer Diagnosis Increases Mortality Risk After Primary PCI for STEMI

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

Conversations in Cardiology: Plavix and PPI

SES Show Advantage Over ZES, PES for Diabetic Patients

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content